Academic Practice at Beth Israel Deaconess Medical Center
Rheumatology
Dr. Vasileios Kyttaris, MD
|
|
Give Review
Vasileios Kyttaris works in the field of Rheumatology. He has 2 awards "Fellow" and "Fellow (FACR)". Vasileios Kyttaris is a published doctor as well. He has 61 publications published. The latest was: T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus. Doctor Vasileios Kyttaris, MD is registered with Medicare.
Publications
- A quantitative lateral flow assay to detect complement activation in blood.
- Stat3 promotes IL-10 expression in lupus T Cells through trans-activation and chromatin remodeling.
- A T cell gene expression panel for the diagnosis and monitoring of Disease activity in patients with systemic lupus erythematosus.
- cAMP Responsive Element Modulator (CREM) α Mediates Chromatin Remodeling of CD8 during the Generation of CD3+CD4-CD8- T Cells.
- cAMP-responsive Element Modulator α (CREMα) trans-Represses the Transmembrane Glycoprotein CD8 and Contributes to the Generation of CD3+CD4-CD8- T Cells in Health and ...
- Small molecules in the treatment of systemic Lupus erythematosus.
- Treatment of SLE: Current paradigm and future directions.
- Identification of Orch3, a locus controlling dominant resistance to autoimmune orchitis, as kinesin family member 1C.
- T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus.
- Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling.
- Treatment with anti-interleukin 23 antibody ameliorates Disease in lupus-prone mice.
- Calciphylaxis: a pseudo-vasculitis Syndrome.
- Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T Cells from patients with systemic lupus erythematosus.
- Phosphorylated ERM is responsible for increased T Cell polarization, adhesion, and migration in patients with systemic lupus erythematosus.
- CAMP response element modulator a expression in patients with systemic Lupus erythematosus.
- Systems biology in systemic Lupus erythematosus: integrating genes, biology and immune function.
- Ocular manifestations of systemic Lupus erythematosus: a clinical review.
- Gene therapy in systemic Lupus erythematosus.
- New insights into the pathogenesis of systemic Lupus erythematosus.
- The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain.
- Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic Lupus erythematosus.
- Increased caspase-3 expression and activity contribute to reduced CD3zeta expression in systemic lupus erythematosus T Cells.
- Immune Cells and cytokines in systemic lupus erythematosus: an update.
- Systemic Lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.
- Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T Cells from patie...
- T lymphocytes in systemic Lupus erythematosus: an update.
- A novel intronic CREM promoter is regulated by AP-1 and accounts for altered activation-induced CREM expression in T Cells from patients with systemic lupus erythemato...
- Targeting lymphocyte signaling pathways as a therapeutic approach to systemic Lupus erythematosus.
- Calcium signaling in systemic lupus erythematosus T cells: A treatment target.
- Promoter hypomethylation results in increased expression of protein phosphatase 2A in T Cells from patients with systemic lupus erythematosus.
- Systemic lupus erythematosus serum deposits C4d on red blood Cells, decreases red blood Cell membrane deformability, and promotes nitric oxide production.
- A systemic lupus erythematosus gene expression array in Disease diagnosis and classification: a preliminary report.
- Systemic Lupus erythematosus: from genes to organ damage.
- Chemosis as a presenting symptom of systemic Lupus erythematosus.
- Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway.
- T Cells as therapeutic targets in SLE.
- Cutting edge: IL-23 receptor deficiency prevents the development of Lupus nephritis in C57BL/6-lpr/lpr mice.
- Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with Disease activity.
- Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.
- Pathogenesis of human systemic Lupus erythematosus: recent advances.
- The role of IL-23/IL-17 axis in Lupus nephritis.
- Sterile empyematous pleural effusion in a patient with systemic Lupus erythematosus: a diagnostic challenge.
- Expanded double negative T Cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
- Elf-1 binds to GGAA elements on the FcRgamma promoter and represses its expression.
- Syk kinase as a treatment target for therapy in autoimmune Diseases.
- Altered signal transduction in SLE T Cells.
- PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T Cells.
- T cells and in situ cryoglobulin Deposition in the pathogenesis of lupus nephritis.
- The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T Cell receptor-associated CD3 complex.
- Whole genome association study results shed light on elusive aetiopathogenesis of systemic Lupus erythematosus.
- How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T Cell phenotype.
- Increased Expression of SLAM Receptors SLAMF3 and SLAMF6 in Systemic Lupus Erythematosus T Lymphocytes Promotes Th17 Differentiation.
- cAMP response element modulator (CREM)? suppresses IL-17F expression in T lymphocytes from patients with systemic Lupus erythematosus (SLE).
- Targeting B Cells in severe thrombotic thrombocytopenic purpura--a road to cure?
- Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies.
- Systemic Lupus erythematosus: new molecular targets.
- Increased expression of STAT3 in SLE T Cells contributes to enhanced chemokine-mediated Cell migration.
- Differential expression and molecular associations of Syk in systemic lupus erythematosus T Cells.
- Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta.
- Uncovering the genetics of systemic Lupus erythematosus: implications for therapy.
Schools
University Of Patras School Of Health Sciences
Washington Hospital Center
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
Conditions Treated
- Achilles Tendinitis
- Arthritis
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow
- Fellow (FACR)
Education
-
Georgetown University Hospital - Washington Hospital Center
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1851344139 | |
| NPPES Provider LastName | KYTTARIS | |
| NPPES Provider FirstName | VASILEIOS | |
| NPPES Provider ZIPCode | 022155501 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 296.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 6.76 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851344139 |
| Last Name Of The Provider | KYTTARIS |
| First Name Of The Provider | VASILEIOS |
| View All |
Similar Doctors
|
|
Dr. Patricia A. Fraser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis A. Arias-Urdaneta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seoyoung C. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart A. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. K F. Austen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Malgorzata I. Dawiskiba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Simms, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Grace H. Lo, MD |
|
|
Dr. Ji Y. Lee, MD |